Glycaemic monitoring and control among high-risk patients with type 2 diabetes in Australian general practice during COVID-19
| Autor: | Evan Atlantis, Kirrilee Jane Barlow, Paul P Fahey |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2023 |
| Předmět: | |
| Zdroj: | Family Medicine and Community Health, Vol 11, Iss 3 (2023) |
| Druh dokumentu: | article |
| ISSN: | 2305-6983 2009-8774 |
| DOI: | 10.1136/fmch-2023-002271 |
| Popis: | Background The COVID-19 pandemic disrupted general practice worldwide, primarily due to public health measures that restricted access to care for chronic diseases, such as type 2 diabetes. These measures disproportionately affected higher risk groups with type 2 diabetes, such as older people and those with obesity. This study aims to identify factors that may have influenced the rates of compliance with testing guidelines and target glycaemic control in Australian general practice settings during the COVID-19 pandemic.Methods We used a serial cross-sectional study design of patient record data from general practices representative of the Nepean Blue Mountains Local Health District between 2020 and 2022. Aggregated patient records were analysed to determine percentages of subgroups with a blood glycaemic testing interval consistent with guidelines (≥1 within 15 months) and achieving target glycaemic control (by glycated haemoglobin of ≤7%). Linear regression models were used to test the association between independent and dependent variables, and to generate regression coefficients and 95% CI, corrected for time trends.Results Of the average 14 356 patient records per month, 55% were male, 53% had a body mass index (BMI) |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|